Save
The European Society of Gynaecological Oncology | ESGO.org
Session 1 | Coping and adjustment with cancer
ESGO eAcademy, Joachim Weis, 346429
Psychooncology e-Module
ESGO eAcademy, Joachim Weis, 346434
Session 2 | Psycho-oncological interventions - Part IV
ESGO eAcademy, Joachim Weis, 346433
Session 2 | Psycho-oncological interventions - Part III
ESGO eAcademy, Joachim Weis, 346432
Session 2 | Psycho-oncological interventions - Part II
ESGO eAcademy, Joachim Weis, 346431
Session 2 | Psycho-oncological interventions - Part I
ESGO eAcademy, Joachim Weis, 346430
Session 1 | Psychosocial distress in cancer patients
ESGO eAcademy, Joachim Weis, 346428
Session 1 | Introduction to Psycho-Oncology P-O care system
ESGO eAcademy, Joachim Weis, 346427
Evaluation Form & Certificate
ESGO eAcademy, Faculty / Presenters, 346377
Inspiring leaders interview with prof. Andreas du Bois
ESGO eAcademy, Luis Chiva, 345839
How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion?
ESGO eAcademy, Gwenael Ferron, 346307
Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators
ESGO eAcademy, Felix Boria, 346306
Principles of urinary reconstruction in gynecologic oncology
ESGO eAcademy, Faculty / Presenters, 345842
Principles of urinary reconstruction in gynecologic oncology
ESGO eAcademy, Faculty / Presenters, 336197
Registration form
ESGO eAcademy, Faculty / Presenters, 336196
Novel screening concepts in ovarian cancer
ESGO eAcademy, John Krell, 344908
Imaging modalities in ovarian cancer diagnosis
ESGO eAcademy, Dirk Timmerman, 344906
Anaesthetic considerations and fragility scores for patients’ stratification prior to surgery
ESGO eAcademy, Emmanuel Stamatakis, 344909
Sentinel node concepts in ovarian cancer
ESGO eAcademy, Anna Fagotti, 344910
Low grade and mucinous histology an overview
ESGO eAcademy, Philippe Morice, 344911
COVID-19 and Ovarian cancer – a game changer
ESGO eAcademy, Dimitrios Haidopoulos, 344912
Value of surgery in relapsed epithelial ovarian cancer
ESGO eAcademy, Andreas du Bois, 344913
Quality assurance programs and metrics in Ovarian cancer surgery
ESGO eAcademy, Christina Fotopoulou, 344914
Reconstructive bowel surgery techniques for ovarian cytoreduction
ESGO eAcademy, Gwenael Ferron, 344915
Quality of life metrics after radical debulking surgery
ESGO eAcademy, Sudha Sundar, 344916
Regimens and novel aspects of oncologic follow up
ESGO eAcademy, Dimitros Tsolakidis, 344917
Complementary anti-cancer therapies: caveats and benefits
ESGO eAcademy, Jalid Sehouli, 344918
What do the patients with ovarian cancer expect from us? An anthropological perspective
ESGO eAcademy, Luis Chiva, 344919
ENYGO LiFE Report - 13th edition
ESGO eAcademy, Charalampos Theofanakis, 344685
Session 2: HRD Testing | HRD and genetic testing
ESGO eAcademy, Rowan Miller, 341924
HRD testing and PARP Inhibitors e-Module
ESGO eAcademy, Faculty / Presenters, 341920
Session 1: PARP inhibitors | PARP in recurrent disease
ESGO eAcademy, Frederik Marmé, 341921
Session 1: PARP inhibitors | First line
ESGO eAcademy, Domenica Lorusso, 341922
Session 1: PARP inhibitors | Future combinations
ESGO eAcademy, Iain McNeish, 341923
Session 2: HRD Testing | Other ways of looking at phenomenon of HRD - perhaps the European (ENGOT) initiative on HRD assays?
ESGO eAcademy, Alexandra Leary, 341926
Session 2: HRD Testing | How HRD and genetic testing might be applied to using PARP inhibitors
ESGO eAcademy, Jose Alejandro Perez-Fidalgo, 341925
Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors
ESGO eAcademy, Dimitrios Nasioudis, 342897
Webinar 5: Tools for Successfull Scientific Presentations
ESGO eAcademy, Pedro Ramirez, 337405
Webinar 3: Steps to Peer Review Process
ESGO eAcademy, René Pareja, 337403
Webinar 2: Structuring a Scientific Manuscript
ESGO eAcademy, Christina Fotopoulou, 337402
Webinar 1: Strategies for Scientific Publication and Literature Analysis
ESGO eAcademy, Pedro Ramirez, 337401
Complication Management: Common complications of upper abdomen surgery
ESGO eAcademy, Sascha Santosh Chopra, 337200
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer - Spanish
ESGO eAcademy, Faculty / Presenters, 336699
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer - Italian
ESGO eAcademy, Faculty / Presenters, 336698
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer - German
ESGO eAcademy, Faculty / Presenters, 336697
Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer - French
ESGO eAcademy, Faculty / Presenters, 336696
Assessment of anastomotic perfusion using indocyanine green fluorescence angiography following bowel resection for gynecologic malignancies: an instructional surgical video 
ESGO eAcademy, Taymaa May, 336693
Introduction to GO training and the new ESGO eLogbook Webinar
ESGO eAcademy, Faculty / Presenters, 336570
Evaluation Form & Certificate
ESGO eAcademy, Faculty / Presenters, 333814
Complication Management Urogenital Tract
ESGO eAcademy, Joerg Neymeyer, 336079
Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lypmhadenectomy for vulvar cancer
ESGO eAcademy, Faculty / Presenters, 336069
Session 5: Molecular Tumour Boards
ESGO eAcademy, Faculty / Presenters, 333245
Endocervical adenocarcinoma – clinical case Silva pattern-based personalized risk stratification system for clinical implementation Case study 1 (interactive)
ESGO eAcademy, Andrei Pletnev, 333243
How to establish Molecular Tumour Boards in Clinical Practice (interactive)
ESGO eAcademy, Tjalling Bosse, 333241
Introduction
ESGO eAcademy, Faculty / Presenters, 333240
Session 5: Molecular Tumour Boards | DAY 2 - July 2nd, 2021 - 12:05-13:10 CEST
ESGO eAcademy, Faculty / Presenters, 333238
Immunotherapy and Immuno-targeting HPV as a therapeutic strategy
ESGO eAcademy, Anna Fagotti, 333236
Session 4: Cervical and Vulvar Cancer
ESGO eAcademy, Faculty / Presenters, 333237
Vaccination strategies and role in the prevention and treatment of (cervical and) vulvar cancer
ESGO eAcademy, Elmar Joura, 333235
HPV- role as a driver for carcinogenesis and a biomarker for diagnosis of cervical cancer; molecular pathology of cervical and vulvar cancer
ESGO eAcademy, Tjalling Bosse, 333234
Introduction
ESGO eAcademy, Faculty / Presenters, 333233
Session 4: Cervical and Vulvar Cancer | DAY 2 - July 2nd, 2021 - 10:50-12:05 CEST
ESGO eAcademy, Faculty / Presenters, 333231
Session 3: Endometrial Cancers
ESGO eAcademy, Faculty / Presenters, 333230
Molecular and genetic characteristics of Trophoblastic tumours
ESGO eAcademy, Baljeet Kaur, 333229
Immuno-targeted therapy of Endometrial Cancer
ESGO eAcademy, Judith Kroep, 333228
Using the molecular classification of Endometrial Cancers to select adjuvant therapies
ESGO eAcademy, Carien Creutzberg, 333227
Lynch Syndrome, DNA repair genes, microsatellite instability and hormonal drivers in the development of Endometrial cancer
ESGO eAcademy, Naveena Singh, 333226
New molecular classification of Endometrial cancers: routine pathology diagnostics in endometrioid and non-endometrioid cancers?
ESGO eAcademy, Tjalling Bosse, 333225
Introduction
ESGO eAcademy, Faculty / Presenters, 333224
Session 3: Endometrial Cancers | DAY 2 - July 2nd, 2021 - 8:30-10:50 AM CEST
ESGO eAcademy, Faculty / Presenters, 333222
Session 2: Rare Gynaecological Tumours
ESGO eAcademy, Faculty / Presenters, 333221
Pathology and Molecular characteristics of Germ Cell tumours
ESGO eAcademy, Baljeet Kaur, 333220
Molecular and Genetic identifiers of Clear Cell Tumours as potential therapeutic targets
ESGO eAcademy, Xavier Matias-Guiu, 333219
Introduction
ESGO eAcademy, Faculty / Presenters, 333217
Session 2: Rare Gynaecological Tumours | DAY 1 - July 1st, 2021 - 11:20-12:35 CEST
ESGO eAcademy, Faculty / Presenters, 333215
Molecular and genetic pathways and characteristics of low-grade cancers (serous and others)
ESGO eAcademy, Glenn McCluggage, 333218
Welcome Message
ESGO eAcademy, Faculty / Presenters, 333204
Session 1: Molecular Markers in High Grade Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 333214
Targeting HR Deficiency- when and with which agents?
ESGO eAcademy, Jonathan Ledermann, 333213
Homologous Recombination Repair - How should HRD be determined and is it clinically useful? (incl. ovarian and endometrial cancers)
ESGO eAcademy, Xavier Matias-Guiu, 333212
Angiogenic pathways- significance in ovarian cancer and role of targeted anti-angiogenic therapy
ESGO eAcademy, Jonathan Ledermann, 333211
Conference Program
ESGO eAcademy, Faculty / Presenters, 330729
CA125 and serological markers of ovarian cancer- Anything new in last decade?
ESGO eAcademy, Anna Fagotti, 333210
BRCA mutations – Pathological and Variants of unknown significance and other genes associated with hereditary ovarian cancer
ESGO eAcademy, Naveena Singh, 333209
Introduction
ESGO eAcademy, Faculty / Presenters, 333207
Session 1: Molecular Markers in High Grade Ovarian Cancer | DAY 1 - July 1st, 2021 - 08:30-11:20 CEST
ESGO eAcademy, Faculty / Presenters, 333205
P53 mutations, Precursor lesions mutations and immunological markers- what do they signify?
ESGO eAcademy, Glenn McCluggage, 333208
SLN mapping in endometrial cancer
ESGO eAcademy, Faculty / Presenters, 330580
Removal of the upper lymphovascular paracervical tissue as a part of a pelvic SLN algorithm
ESGO eAcademy, Jan Persson, 333322
Robotic paraaortic SLN detection following injection of ICG in the IP-ligaments
ESGO eAcademy, Jan Persson, 333321
Robot-assisted transperitoneal paraaortic lymphadenectomy
ESGO eAcademy, Henrik Falconer, 333319
Sentinel lymph node detection along the lower paracervical lymphatic pathway
ESGO eAcademy, Jan Persson, 333318
Tips and Trick for Obese Patients: Robotic Transperitoneal Aortic Lymphadenectomy
ESGO eAcademy, Jordi Ponce, 333316
Cervical cancer elimination - it is possible or not?
ESGO eAcademy, Faculty / Presenters, 333260
Pelvic anatomy for gynecologic oncologists: Autonomic bladder plexus
ESGO eAcademy, Faculty / Presenters, 332162
Pelvic sentinel node detection along the upper paracervical pathway
ESGO eAcademy, Jan Persson, 332138
Paraaortic mapping NIF Firefly: ICG mediated visualization of paraaortic compartmental lymph nodes
ESGO eAcademy, Rainer Kimmig, 332137
Robotic assisted laparoscopic paraaortic access and lymphadenectomy in 10 steps
ESGO eAcademy, Delphine Hudry, 332136

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings